光子计数探测器CT对多发性骨髓瘤患者图像质量与辐射剂量的影响
前瞻性研究纳入35例已知多发性骨髓瘤患者,行临床指征全身光子计数探测器CT(PCD-CT),并与能量积分探测器CT(EID-CT)对照。PCD-CT在整体图像质量、边缘锐利度、图像噪声、病灶 conspicuity 及诊断信心方面主观评分更优,定量信号均匀性更好(CV 0.99±0.65 vs 1.66±0.5,P<0.001),FWHM更低(2.89 vs 25.68 cy/pixel),辐射剂量更低(CTDIvol 3.33±0.82 vs 7.19±3.57 mGy,P<0.001)。
要点
- PCD-CT较EID-CT主观图像质量各维度评分更优(P≤0.004),诊断信心更高。
- PCD-CT定量信号均匀性更佳(CV 0.99±0.65 vs 1.66±0.5,P<0.001),FWHM更低(2.89 vs 25.68 cy/pixel)。
- PCD-CT辐射剂量显著低于EID-CT(CTDIvol 3.33±0.82 vs 7.19±3.57 mGy,P<0.001)。
核心结论
- 全身PCD-CT较当前临床标准EID-CT协议提供显著更高的主观和客观图像质量,辐射剂量显著降低,并可即时获得多光谱数据,便于进一步高级后处理。
研究设计与样本
- 前瞻性研究,纳入35例已知多发性骨髓瘤患者(平均年龄69.8±9.1岁,男性18例[51%]),行临床指征全身PCD-CT,以当前临床标准EID-CT协议为对照。
诊断标准与关键数值
- 主观图像质量采用5分Likert量表(5=极好),由三名独立放射科医师评估整体图像质量、边缘锐利度、图像噪声、病灶 conspicuity 和诊断信心。
- PCD-CT vs EID-CT中位(四分位距)评分:整体图像质量4.0(4.0-5.0)vs 4.0(3.0-4.0),边缘锐利度4.0(4.0-5.0)vs 4.0(3.0-4.0),图像噪声4.0(4.0-4.0)vs 3.0(3.0-4.0),病灶 conspicuity 4.0(4.0-5.0)vs 4.0(3.0-4.0),诊断信心4.0(4.0-5.0)vs 4.0(3.0-4.0),P≤0.004。
- 定量信号均匀性:PCD-CT平均CV±SD 0.99±0.65 vs EID-CT 1.66±0.5,P<0.001。
- 调制传递函数半高全宽(FWHM):PCD-CT 2.89 vs EID-CT 25.68 cy/pixel。
- 辐射剂量平均CTDIvol±SD:PCD-CT 3.33±0.82 mGy vs EID-CT 7.19±3.57 mGy,P<0.001。
局限性
- 原文未报告局限性。
以上解读依据论文摘要(全文未开放获取或许可不允许翻译转载)。
英文原文(摘要)· 点击展开
OBJECTIVE: Computed tomography (CT) is an established method for the diagnosis, staging, and treatment of multiple myeloma. Here, we investigated the potential of photon-counting detector computed tomography (PCD-CT) in terms of image quality, diagnostic confidence, and radiation dose compared with energy-integrating detector CT (EID-CT).
MATERIALS AND METHODS: In this prospective study, patients with known multiple myeloma underwent clinically indicated whole-body PCD-CT. The image quality of PCD-CT was assessed qualitatively by three independent radiologists for overall image quality, edge sharpness, image noise, lesion conspicuity, and diagnostic confidence using a 5-point Likert scale (5 = excellent), and quantitatively for signal homogeneity using the coefficient of variation (CV) of Hounsfield Units (HU) values and modulation transfer function (MTF) via the full width at half maximum (FWHM) in the frequency space. The results were compared with those of the current clinical standard EID-CT protocols as controls. Additionally, the radiation dose (CTDIvol) was determined.
RESULTS: We enrolled 35 patients with multiple myeloma (mean age 69.8 ± 9.1 years; 18 [51%] males). Qualitative image analysis revealed superior scores (median [interquartile range]) for PCD-CT regarding overall image quality (4.0 [4.0-5.0] vs. 4.0 [3.0-4.0]), edge sharpness (4.0 [4.0-5.0] vs. 4.0 [3.0-4.0]), image noise (4.0 [4.0-4.0] vs. 3.0 [3.0-4.0]), lesion conspicuity (4.0 [4.0-5.0] vs. 4.0 [3.0-4.0]), and diagnostic confidence (4.0 [4.0-5.0] vs. 4.0 [3.0-4.0]) compared with EID-CT (P ≤ 0.004). In quantitative image analyses, PCD-CT compared with EID-CT revealed a substantially lower FWHM (2.89 vs. 25.68 cy/pixel) and a significantly more homogeneous signal (mean CV ± standard deviation [SD], 0.99 ± 0.65 vs. 1.66 ± 0.5; P < 0.001) at a significantly lower radiation dose (mean CTDIvol ± SD, 3.33 ± 0.82 vs. 7.19 ± 3.57 mGy; P < 0.001).
CONCLUSION: Whole-body PCD-CT provides significantly higher subjective and objective image quality at significantly reduced radiation doses than the current clinical standard EID-CT protocols, along with readily available multi-spectral data, facilitating the potential for further advanced post-processing.
引用
- Rau A, Neubauer J, Taleb L, et al. Impact of Photon-Counting Detector Computed Tomography on Image Quality and Radiation Dose in Patients With Multiple Myeloma. Korean J Radiol. 2023. PMID: 37724589. doi:10.3348/kjr.2023.0211
供执业医师工作参考,不替代临床判断;数值与分级以指南原文为准。